切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - P-glycoprotein (P-gp) - Sir2-like Family Deacetylases (Sirtuins) - Hec1 - Inward Rectifier Potassium (Kir) Channels

19件产品中的 1-10

页面
每页
清除全部
  1. Inauhzin
    B3272 Inauhzin
    Target: Sir2-like Family Deacetylases (Sirtuins)
    Summary: SIRT1抑制剂
      ≥23.5 mg/mL
      insoluble in H2O
  2. TAI-1
    B4892 TAI-1
    Target: Hec1
    Summary: Hec1抑制剂
      ≥43.2 mg/mL
      insoluble in H2O
  3. Nateglinide
    B2198 Nateglinide
    中文名: 那格列奈
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素促分泌剂
      ≥16.4 mg/mL
      insoluble in H2O
  4. Gliclazide
    B2195 Gliclazide
    中文名: 格列齐特
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥15.6 mg/mL
      insoluble in H2O
  5. Mitiglinide Calcium
    B2193 Mitiglinide Calcium
    中文名: 米格列奈钙
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥33.45 mg/mL
      insoluble in H2O
  6. Glibenclamide
    B1296 Glibenclamide
    中文名: 格列本脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素生产调节剂
      ≥49.4 mg/mL
      insoluble in H2O
  7. LY335979 (Zosuquidar 3HCL)
    A8549 LY335979 (Zosuquidar 3HCL)
     1 Citation
    中文名: 唑喹达三盐酸盐
    Target: P-glycoprotein (P-gp)
    Summary: Pgb(P糖蛋白)抑制剂
      ≥17.1 mg/mL
      ≥31.9 mg/mL
  8. Terfenadine
    A8534 Terfenadine
    中文名: 特非那定
    Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) Channels
    Summary: 组胺H1受体拮抗剂
      ≥18 mg/mL
      insoluble in H2O
  9. Tenovin-6
    A8302 Tenovin-6
    Target: Sir2-like Family Deacetylases (Sirtuins)
    Summary: SIRT抑制剂,p53激活剂
      ≥22.75 mg/mL
      insoluble in H2O
  10. Zosuquidar
    A3956 Zosuquidar
    Target: P-glycoprotein (P-gp)|Cytochrome P450 (CYP450)
    Summary: MDR调节剂
      Soluble in DMSO

19件产品中的 1-10

页面
每页